Anti-obesity Medicine Market, Global Outlook and Forecast 2023-2029
Report Code: KNJ1551603 No. of Pages: 60 Category: Pharmaceuticals and Healthcare
Publisher: Date of Publish:
Publisher: Date of Publish:
Anti-obesity medication or weight loss medications are pharmacological agents that reduce or control weight.
This report aims to provide a comprehensive presentation of the global market for Anti-obesity Medicine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-obesity Medicine. This report contains market size and forecasts of Anti-obesity Medicine in global, including the following market information:
Global Anti-obesity Medicine Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Anti-obesity Medicine market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Prescription Drugs Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Anti-obesity Medicine include Alizyme, Amylin Pharmaceuticals, Arena Pharmaceuticals, Boehringer Ingelheim, Eisai, GlaxoSmithKline, Orexigen Therapeutics, Vivus and Pfizer, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Anti-obesity Medicine companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Anti-obesity Medicine Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Anti-obesity Medicine Market Segment Percentages, by Type, 2022 (%)
Prescription Drugs
OTC Drugs
Global Anti-obesity Medicine Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Anti-obesity Medicine Market Segment Percentages, by Application, 2022 (%)
Men
Women
Global Anti-obesity Medicine Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Anti-obesity Medicine Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Anti-obesity Medicine revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Anti-obesity Medicine revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Alizyme
Amylin Pharmaceuticals
Arena Pharmaceuticals
Boehringer Ingelheim
Eisai
GlaxoSmithKline
Orexigen Therapeutics
Vivus
Pfizer
Roche
Merck
Novo Nordisk
Outline of Major Chapters:
Chapter 1: Introduces the definition of Anti-obesity Medicine, market overview.
Chapter 2: Global Anti-obesity Medicine market size in revenue.
Chapter 3: Detailed analysis of Anti-obesity Medicine company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Anti-obesity Medicine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Anti-obesity Medicine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Anti-obesity Medicine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Anti-obesity Medicine Overall Market Size
2.1 Global Anti-obesity Medicine Market Size: 2022 VS 2029
2.2 Global Anti-obesity Medicine Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Anti-obesity Medicine Players in Global Market
3.2 Top Global Anti-obesity Medicine Companies Ranked by Revenue
3.3 Global Anti-obesity Medicine Revenue by Companies
3.4 Top 3 and Top 5 Anti-obesity Medicine Companies in Global Market, by Revenue in 2022
3.5 Global Companies Anti-obesity Medicine Product Type
3.6 Tier 1, Tier 2 and Tier 3 Anti-obesity Medicine Players in Global Market
3.6.1 List of Global Tier 1 Anti-obesity Medicine Companies
3.6.2 List of Global Tier 2 and Tier 3 Anti-obesity Medicine Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Anti-obesity Medicine Market Size Markets, 2022 & 2029
4.1.2 Prescription Drugs
4.1.3 OTC Drugs
4.2 By Type - Global Anti-obesity Medicine Revenue & Forecasts
4.2.1 By Type - Global Anti-obesity Medicine Revenue, 2018-2023
4.2.2 By Type - Global Anti-obesity Medicine Revenue, 2024-2029
4.2.3 By Type - Global Anti-obesity Medicine Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Anti-obesity Medicine Market Size, 2022 & 2029
5.1.2 Men
5.1.3 Women
5.2 By Application - Global Anti-obesity Medicine Revenue & Forecasts
5.2.1 By Application - Global Anti-obesity Medicine Revenue, 2018-2023
5.2.2 By Application - Global Anti-obesity Medicine Revenue, 2024-2029
5.2.3 By Application - Global Anti-obesity Medicine Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Anti-obesity Medicine Market Size, 2022 & 2029
6.2 By Region - Global Anti-obesity Medicine Revenue & Forecasts
6.2.1 By Region - Global Anti-obesity Medicine Revenue, 2018-2023
6.2.2 By Region - Global Anti-obesity Medicine Revenue, 2024-2029
6.2.3 By Region - Global Anti-obesity Medicine Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Anti-obesity Medicine Revenue, 2018-2029
6.3.2 US Anti-obesity Medicine Market Size, 2018-2029
6.3.3 Canada Anti-obesity Medicine Market Size, 2018-2029
6.3.4 Mexico Anti-obesity Medicine Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Anti-obesity Medicine Revenue, 2018-2029
6.4.2 Germany Anti-obesity Medicine Market Size, 2018-2029
6.4.3 France Anti-obesity Medicine Market Size, 2018-2029
6.4.4 U.K. Anti-obesity Medicine Market Size, 2018-2029
6.4.5 Italy Anti-obesity Medicine Market Size, 2018-2029
6.4.6 Russia Anti-obesity Medicine Market Size, 2018-2029
6.4.7 Nordic Countries Anti-obesity Medicine Market Size, 2018-2029
6.4.8 Benelux Anti-obesity Medicine Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Anti-obesity Medicine Revenue, 2018-2029
6.5.2 China Anti-obesity Medicine Market Size, 2018-2029
6.5.3 Japan Anti-obesity Medicine Market Size, 2018-2029
6.5.4 South Korea Anti-obesity Medicine Market Size, 2018-2029
6.5.5 Southeast Asia Anti-obesity Medicine Market Size, 2018-2029
6.5.6 India Anti-obesity Medicine Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Anti-obesity Medicine Revenue, 2018-2029
6.6.2 Brazil Anti-obesity Medicine Market Size, 2018-2029
6.6.3 Argentina Anti-obesity Medicine Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Anti-obesity Medicine Revenue, 2018-2029
6.7.2 Turkey Anti-obesity Medicine Market Size, 2018-2029
6.7.3 Israel Anti-obesity Medicine Market Size, 2018-2029
6.7.4 Saudi Arabia Anti-obesity Medicine Market Size, 2018-2029
6.7.5 UAE Anti-obesity Medicine Market Size, 2018-2029
7 Anti-obesity Medicine Companies Profiles
7.1 Alizyme
7.1.1 Alizyme Company Summary
7.1.2 Alizyme Business Overview
7.1.3 Alizyme Anti-obesity Medicine Major Product Offerings
7.1.4 Alizyme Anti-obesity Medicine Revenue in Global Market (2018-2023)
7.1.5 Alizyme Key News & Latest Developments
7.2 Amylin Pharmaceuticals
7.2.1 Amylin Pharmaceuticals Company Summary
7.2.2 Amylin Pharmaceuticals Business Overview
7.2.3 Amylin Pharmaceuticals Anti-obesity Medicine Major Product Offerings
7.2.4 Amylin Pharmaceuticals Anti-obesity Medicine Revenue in Global Market (2018-2023)
7.2.5 Amylin Pharmaceuticals Key News & Latest Developments
7.3 Arena Pharmaceuticals
7.3.1 Arena Pharmaceuticals Company Summary
7.3.2 Arena Pharmaceuticals Business Overview
7.3.3 Arena Pharmaceuticals Anti-obesity Medicine Major Product Offerings
7.3.4 Arena Pharmaceuticals Anti-obesity Medicine Revenue in Global Market (2018-2023)
7.3.5 Arena Pharmaceuticals Key News & Latest Developments
7.4 Boehringer Ingelheim
7.4.1 Boehringer Ingelheim Company Summary
7.4.2 Boehringer Ingelheim Business Overview
7.4.3 Boehringer Ingelheim Anti-obesity Medicine Major Product Offerings
7.4.4 Boehringer Ingelheim Anti-obesity Medicine Revenue in Global Market (2018-2023)
7.4.5 Boehringer Ingelheim Key News & Latest Developments
7.5 Eisai
7.5.1 Eisai Company Summary
7.5.2 Eisai Business Overview
7.5.3 Eisai Anti-obesity Medicine Major Product Offerings
7.5.4 Eisai Anti-obesity Medicine Revenue in Global Market (2018-2023)
7.5.5 Eisai Key News & Latest Developments
7.6 GlaxoSmithKline
7.6.1 GlaxoSmithKline Company Summary
7.6.2 GlaxoSmithKline Business Overview
7.6.3 GlaxoSmithKline Anti-obesity Medicine Major Product Offerings
7.6.4 GlaxoSmithKline Anti-obesity Medicine Revenue in Global Market (2018-2023)
7.6.5 GlaxoSmithKline Key News & Latest Developments
7.7 Orexigen Therapeutics
7.7.1 Orexigen Therapeutics Company Summary
7.7.2 Orexigen Therapeutics Business Overview
7.7.3 Orexigen Therapeutics Anti-obesity Medicine Major Product Offerings
7.7.4 Orexigen Therapeutics Anti-obesity Medicine Revenue in Global Market (2018-2023)
7.7.5 Orexigen Therapeutics Key News & Latest Developments
7.8 Vivus
7.8.1 Vivus Company Summary
7.8.2 Vivus Business Overview
7.8.3 Vivus Anti-obesity Medicine Major Product Offerings
7.8.4 Vivus Anti-obesity Medicine Revenue in Global Market (2018-2023)
7.8.5 Vivus Key News & Latest Developments
7.9 Pfizer
7.9.1 Pfizer Company Summary
7.9.2 Pfizer Business Overview
7.9.3 Pfizer Anti-obesity Medicine Major Product Offerings
7.9.4 Pfizer Anti-obesity Medicine Revenue in Global Market (2018-2023)
7.9.5 Pfizer Key News & Latest Developments
7.10 Roche
7.10.1 Roche Company Summary
7.10.2 Roche Business Overview
7.10.3 Roche Anti-obesity Medicine Major Product Offerings
7.10.4 Roche Anti-obesity Medicine Revenue in Global Market (2018-2023)
7.10.5 Roche Key News & Latest Developments
7.11 Merck
7.11.1 Merck Company Summary
7.11.2 Merck Business Overview
7.11.3 Merck Anti-obesity Medicine Major Product Offerings
7.11.4 Merck Anti-obesity Medicine Revenue in Global Market (2018-2023)
7.11.5 Merck Key News & Latest Developments
7.12 Novo Nordisk
7.12.1 Novo Nordisk Company Summary
7.12.2 Novo Nordisk Business Overview
7.12.3 Novo Nordisk Anti-obesity Medicine Major Product Offerings
7.12.4 Novo Nordisk Anti-obesity Medicine Revenue in Global Market (2018-2023)
7.12.5 Novo Nordisk Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
NEED Help?
If you need any help or guidance, please feel free to call us.
USA : +1 (661) 636 6162
INDIA : +91 9325802062
or
Write us on : sales@kandjmarketresearch.com